PubRank
Search
About
Karl Lhotta
Author PubWeight™ 50.32
‹?›
Top papers
Rank
Title
Journal
Year
PubWeight™
‹?›
1
Fibroblast growth factor 23 (FGF23) predicts progression of chronic kidney disease: the Mild to Moderate Kidney Disease (MMKD) Study.
J Am Soc Nephrol
2007
4.59
2
Mutations in complement C3 predispose to development of atypical hemolytic uremic syndrome.
Blood
2008
3.10
3
Membrane targeting and secretion of mutant uromodulin in familial juvenile hyperuricemic nephropathy.
J Am Soc Nephrol
2006
1.73
4
Targeting of mannan-binding lectin-associated serine protease-2 confers protection from myocardial and gastrointestinal ischemia/reperfusion injury.
Proc Natl Acad Sci U S A
2011
1.58
5
Results of a nationwide screening for Anderson-Fabry disease among dialysis patients.
J Am Soc Nephrol
2004
1.53
6
Uromodulin mutations causing familial juvenile hyperuricaemic nephropathy lead to protein maturation defects and retention in the endoplasmic reticulum.
Hum Mol Genet
2009
1.24
7
The intricate role of complement component C4 in human systemic lupus erythematosus.
Curr Dir Autoimmun
2004
1.15
8
Evidence for a role of uromodulin in chronic kidney disease progression.
Nephrol Dial Transplant
2010
1.14
9
Use of sodium thiosulphate in a multi-interventional setting for the treatment of calciphylaxis in dialysis patients.
Nephrol Dial Transplant
2013
1.09
10
Vitamin D deficiency is associated with poor response to active hepatitis B immunisation in patients with chronic kidney disease.
Vaccine
2011
1.07
11
Complete complement components C4A and C4B deficiencies in human kidney diseases and systemic lupus erythematosus.
J Immunol
2004
1.05
12
Apolipoprotein A-IV predicts progression of chronic kidney disease: the mild to moderate kidney disease study.
J Am Soc Nephrol
2005
1.01
13
Epidemiological approach to identifying genetic predispositions for atypical hemolytic uremic syndrome.
Ann Hum Genet
2010
0.97
14
Prevalence of dyslipidemic risk factors in hemodialysis and CAPD patients.
Kidney Int Suppl
2003
0.94
15
Age-related penetrance of hereditary atypical hemolytic uremic syndrome.
Ann Hum Genet
2011
0.92
16
Mutational analysis of CLC-5, cofilin and CLC-4 in patients with Dent's disease.
Nephron Physiol
2009
0.91
17
Lipoprotein(a)- and low-density lipoprotein-derived cholesterol in nephrotic syndrome: Impact on lipid-lowering therapy?
Kidney Int
2004
0.91
18
Association between genotype and phenotype in uromodulin-associated kidney disease.
Clin J Am Soc Nephrol
2013
0.90
19
Genetic mapping studies of familial juvenile hyperuricemic nephropathy on chromosome 16p11-p13.
J Clin Endocrinol Metab
2003
0.89
20
The serum uromodulin level is associated with kidney function.
Clin Chem Lab Med
2014
0.89
21
Sex-specific association of time-varying haemoglobin values with mortality in incident dialysis patients.
Nephrol Dial Transplant
2010
0.88
22
Flow cytometry based detection of HLA alloantibody mediated classical complement activation.
J Immunol Methods
2003
0.87
23
Coumarins and survival in incident dialysis patients.
Nephrol Dial Transplant
2011
0.87
24
Pharmacokinetic analysis of docetaxel during haemodialysis in a patient with locally advanced non-small cell lung cancer.
Nephrol Dial Transplant
2006
0.87
25
Apolipoprotein A-IV serum concentrations are elevated in patients with mild and moderate renal failure.
J Am Soc Nephrol
2002
0.85
26
Efficacy of eculizumab in a patient with immunoadsorption-dependent catastrophic antiphospholipid syndrome: a case report.
Medicine (Baltimore)
2014
0.85
27
Medullary nephrocalcinosis in an adult patient with idiopathic infantile hypercalcaemia and a novel CYP24A1 mutation.
Clin Kidney J
2013
0.84
28
Interaction of time-varying albumin and phosphorus on mortality in incident dialysis patients.
Clin J Am Soc Nephrol
2011
0.84
29
Association of HbA1c values with mortality and cardiovascular events in diabetic dialysis patients. The INVOR study and review of the literature.
PLoS One
2011
0.84
30
Genome-wide study of familial juvenile hyperuricaemic (gouty) nephropathy (FJHN) indicates a new locus, FJHN3, linked to chromosome 2p22.1-p21.
Hum Genet
2010
0.83
31
Cigarette smoking and chronic allograft nephropathy.
Nephrol Dial Transplant
2007
0.83
32
Neutrophil transmigration in renal proximal tubular LLC-PK1 cells.
Cell Physiol Biochem
2004
0.82
33
Body mass index and metabolic factors predict glomerular filtration rate and albuminuria over 20 years in a high-risk population.
BMC Nephrol
2013
0.82
34
Effect of cinacalcet on renal electrolyte handling and systemic arterial blood pressure in kidney transplant patients with persistent hyperparathyroidism.
Transplantation
2011
0.82
35
Carotid plaques and their predictive value for cardiovascular disease and all-cause mortality in hemodialysis patients considering renal transplantation: a decade follow-up.
Am J Kidney Dis
2006
0.82
36
The association of mid-regional pro-adrenomedullin and mid-regional pro-atrial natriuretic peptide with mortality in an incident dialysis cohort.
PLoS One
2011
0.82
37
Treatment with oral active vitamin D is associated with decreased risk of peritonitis and improved survival in patients on peritoneal dialysis.
PLoS One
2013
0.80
38
Role of the kidney in the metabolism of apolipoprotein A-IV: influence of the type of proteinuria.
J Lipid Res
2006
0.80
39
Apoptosis of human polymorphonuclear neutrophils accelerated by dialysis membranes via the activation of the complement system.
Nephrol Dial Transplant
2004
0.80
40
Juvenile elastic arteries after 28 years of renal replacement therapy in a patient with complete complement C4 deficiency.
BMC Nephrol
2012
0.79
41
Interleukin-19 as a translational indicator of renal injury.
Arch Toxicol
2014
0.79
42
Fenestration of the Gerota's fascia as symptomatic treatment of floating kidneys.
Am J Kidney Dis
2007
0.79
43
Sirolimus-associated acute interstitial nephritis in a renal allograft.
Transpl Int
2009
0.78
44
Kidney transplantation in patients suffering from hereditary complete complement C4 deficiency.
Transpl Int
2007
0.77
45
The apolipoprotein(a) size polymorphism is associated with nephrotic syndrome.
Kidney Int
2004
0.77
46
Apolipoprotein(a) isoform-specific changes of lipoprotein(a) after kidney transplantation.
Eur J Hum Genet
2003
0.76
47
Clearance of C4d deposition after successful treatment of acute humoral rejection in follow-up biopsies: a report of three cases.
Transpl Int
2004
0.76
48
The role of gender in estimating glomerular filtration rate.
Nephrol Dial Transplant
2005
0.75
49
Performance of GFR formulas in individuals with normal renal function.
Am J Kidney Dis
2004
0.75
50
Stopping progression in familial juvenile hyperuricemic nephropathy with benzbromarone?
Kidney Int
2003
0.75
51
Renal cysts and diabetes due to a heterozygous HNF-1beta gene deletion.
Nephrol Dial Transplant
2006
0.75
52
Erratum: Medullary nephrocalcinosis in an adult patient with idiopathic infantile hypercalcaemia and a novel CYP24A1 mutation.
Clin Kidney J
2013
0.75
53
Proteinuria and hemoglobin levels in patients with primary glomerular disease.
Am J Kidney Dis
2005
0.75
54
Colonic perforation associated with leukocytoclastic vasculitis caused by Sirolimus toxicity following renal transplantation.
Transpl Int
2006
0.75
55
Bilateral perirenal fluid accumulation associated with Eisenmenger's syndrome.
Nephrol Dial Transplant
2004
0.75
56
Ochrobactrum anthropi infection in dialysis patients: A case report and literature summary.
Clin Nephrol
2022
0.75
57
A hidden cause of angina pectoris: when ABG analysis is the only helpful diagnostic tool.
Int J Cardiol
2005
0.75